USA FINANCIAL FORMULAS

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1633716 ADA, MI

Position in REGN

as of Mar 31, 2026 · filed Apr 14, 2026 Compact

Position Value

$1,125,736

+$169,299 QoQ

Shares Held

1,457

+60.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

USA FINANCIAL FORMULAS holds $1,729,226 across 7 Biotechnology names. REGN ranks #1 (65.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	1,457	$1,125,736
2	INCY	Incyte Corp	5,204	$489,800
3	KRYS	Krystal Biotech, Inc.	171	$44,172
4	LGND	Ligand Pharmaceuticals Inc	216	$43,124
5	JAZZ	Jazz Pharmaceuticals plc	132	$24,954
6	HALO	Halozyme Therapeutics, Inc.	13	$840
7	EXEL	Exelixis, Inc.	14	$600

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,125,736	1,457	+60.1%	Shares	Sole	2026-04-14
2024-06-30	$956,437	910	+6.8%	Shares	Sole	2024-07-12
2024-03-31	$820,041	852	-68.4%	Shares	Sole	2024-04-30
2023-09-30	$2,217,877	2,695	-0.6%	Shares	Sole	2023-11-27
2023-06-30	$1,948,680	2,712	-32.0%	Shares	Sole	2023-11-27
2023-03-31	$3,276,819	3,988	+398700.0%	Shares	Sole	2023-11-27
2022-09-30	$688	1	0.0%	Shares	Sole	2022-10-24
2022-06-30	$591	1	0.0%	Shares	Sole	2022-08-15
2022-03-31	$698	1	-100.0%	Shares	Sole	2022-08-16
2021-12-31	$1,653,950	2,619	+43550.0%	Shares	Sole	2022-02-10
2021-09-30	$3,631	6	-99.9%	Shares	Sole	2021-11-08
2020-09-30	$2,409,293	4,304	-40.9%	Shares	Sole	2020-10-09
2020-06-30	$4,543,913	7,286	-2.3%	Shares	Sole	2020-08-11
2020-03-31	$3,642,643	7,460	—	Shares	Sole	2020-04-13
No filing history on record for this holder in this stock.